$1.67
-0.16 (-8.74%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,060.5% upside
Low Target
$23.71
Average Target
$36.08
High Target
$52.26
Current Price
$1.67
Current
$1.67
$1.67
Target
$36.08
$36.08
$23.71
$36.08 avg
$52.26
Scenario Analysis
Bear Case
$23.71
1,319.8%
Low target
Base Case
$36.08
+2,060.5%
Avg target
Bull Case
$52.26
+3,029.3%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$10.00
-83.3% from high
52-Week Low
$1.46
+14.4% from low
Target vs 52W High
$36.08
+260.8% vs high
Next Earnings Report
Nov 16, 2026
2d
until earnings
EPS Est: $-0.50
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |